You have 9 free searches left this month | for more free features.

Givinostat hydrochloride

Showing 1 - 25 of 1,787

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Polycythemia Vera Trial (Givinostat Hydrochloride, Hydroxy Urea)

Not yet recruiting
  • Polycythemia Vera
  • Givinostat Hydrochloride
  • Hydroxy Urea
  • (no location specified)
Oct 19, 2023

Duchenne and Becker Muscular Dystrophy, Polycytemia Vera Trial in Québec (ITF2357 10 mg/mL, Placebo, Moxifloxacin Hydrochloride)

Completed
  • Duchenne and Becker Muscular Dystrophy
  • Polycytemia Vera
  • ITF2357 10 mg/mL
  • +2 more
  • Québec, Canada
    Québec
Aug 25, 2021

Duchenne Muscular Dystrophy Trial (Givinostat, Placebo)

Not yet recruiting
  • Duchenne Muscular Dystrophy
  • (no location specified)
Jun 27, 2023

Drug Drug Interaction Trial in Porto (Givinostat)

Completed
  • Drug Drug Interaction
  • Porto, Portugal
    Hospital da Prelada, 3rd Floor & East Wing 4th Floor Rua Sarment
May 5, 2023

Drug-Drug Interaction Trial in Porto (ITF2357 Givinostat 10mg/mL, Midazolam 1Mg/Ml (Pf) Inj Syringe 5Ml, Midazolam Oral Liquid

Completed
  • Drug-Drug Interaction
  • ITF2357 Givinostat 10mg/mL
  • +4 more
  • Porto, Portugal
    Hospital da Prelada, 3rd Floor & East Wing 4th Floor Rua Sarment
Aug 4, 2022

Chronic Myeloproliferative Tumors Trial in Germany, Italy, United Kingdom (givinostat)

Active, not recruiting
  • Chronic Myeloproliferative Neoplasms
  • Berlin, Germany
  • +14 more
Jun 14, 2021

Juvenile Idiopathic Arthritis Trial in Praha (Givinostat)

Terminated
  • Juvenile Idiopathic Arthritis
  • Praha, Czechia
    1st Faculty of Medicine and General Faculty Hospital
Mar 10, 2021

Hodgkin's Lymphoma Trial in Milan (histone deacetylase inhibitor (ITF2357))

Terminated
  • Hodgkin's Lymphoma
  • histone deacetylase inhibitor (ITF2357)
  • Milan, Italy
    Istituto Nazionale per lo studio e la cura dei Tumori
Jan 18, 2022

Chronic Lymphocytic Leukemia Trial in Perugia (ITF2357)

Terminated
  • Chronic Lymphocytic Leukemia
  • Perugia, Italy
    Department of Internal Medicine and Public Health, University of
Jan 18, 2022

Drug Drug Interaction Trial in Porto (Givinostat, Clarithromycin)

Completed
  • Drug Drug Interaction
  • Porto, Portugal
    Hospital da Prelada, 3rd Floor & East Wing 4th Floor Rua Sarment
Apr 26, 2023

Multiple Myeloma Trial in Cagliari (ITF2357)

Terminated
  • Multiple Myeloma
  • Cagliari, Italy
    Presidio Ospedaliero R. Binaghi
Jan 18, 2022

Duchenne Muscular Dystrophy Trial in Worldwide (Givinostat)

Enrolling by invitation
  • Duchenne Muscular Dystrophy
  • Sacramento, California
  • +38 more
Mar 3, 2022

Duchenne Muscular Dystrophy (DMD) Trial in Italy (Givinostat)

Completed
  • Duchenne Muscular Dystrophy (DMD)
  • Messina, Italy
  • +3 more
Jun 9, 2020

Becker Muscular Dystrophy Trial in Milan, Leiden (givinostat, )

Completed
  • Becker Muscular Dystrophy
  • Milan, Italy
  • +1 more
Jan 11, 2022

Diabetic Peripheral Neuropathic Pain Trial in Luoyang (HSK16149 20mg BID)

Recruiting
  • Diabetic Peripheral Neuropathic Pain
  • HSK16149 20mg BID
  • Luoyang, Henan, China
    The First Affiliated Hospital of Henan University of Science and
Nov 2, 2023

Hodgkin's Lymphoma Trial in Milano (ITF2357)

Completed
  • Hodgkin's Lymphoma
  • Milano, Italy
    Istituto Nazionale per la Cura e lo Studio dei Tumori
Apr 20, 2021

Laparoscopy, Anesthesia, Intravenous Trial in China (BT-KTM-I, Ketanest®S)

Not yet recruiting
  • Laparoscopy
  • Anesthesia, Intravenous
  • Guangzhou, Guangdong, China
  • +11 more
Oct 15, 2023

Adult Solid Tumor Trial in Rochester (Erlotinib Hydrochloride, Irinotecan Hydrochloride)

Active, not recruiting
  • Adult Solid Neoplasm
  • Erlotinib Hydrochloride
  • Irinotecan Hydrochloride
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 12, 2023

Pain, Insomnia Trial in Guangzhou (Compound ibuprofen polyrelease tablets, reference 1 (R1): Ibuprofen Tablets (Motrin

Not yet recruiting
  • Pain
  • Insomnia
  • Compound ibuprofen polyrelease tablets
  • reference 1 (R1): Ibuprofen Tablets (Motrin IB®)reference 2 (R2): Diphenhydramine Hydrochloride Tablets (Benadryl®)
  • Guangzhou, Guangdong, China
    Zhujiang Hospital of Southern Medical University
Feb 6, 2023

Breast Cancer Trial in Beijing (Mitoxantrone HCl liposome, Capecitabine)

Not yet recruiting
  • Breast Cancer
  • Beijing, Beijing, China
    Cancer Hospital Chinese Academy of Medical Sciences
Dec 1, 2023

Non Small Cell Lung Cancer, Propranolol Trial (Propranolol HCl, Sintilimab, Chemotherapy)

Not yet recruiting
  • Non Small Cell Lung Cancer
  • Propranolol
  • Propranolol hydrochloride
  • +2 more
  • (no location specified)
Jul 31, 2023

Platinum-resistant Ovarian Cancer Trial in Shanghai (Oral Topotecan Combined With Anlotinib)

Not yet recruiting
  • Platinum-resistant Ovarian Cancer
  • Oral Topotecan Combined With Anlotinib
  • Shanghai, China
    Xinhua Hospital Affiliated to Shanghai Jiaotong University Schoo
Feb 12, 2023

Associated With Cardiomyopathy and Heart Failure After Cancer

Recruiting
  • Hodgkin Lymphoma in Remission
  • +6 more
  • Assessment of Therapy Complications
  • +3 more
  • Birmingham, Alabama
  • +78 more
Jan 11, 2023

Nalbuphine Allergy, Ablation, Safety Trial in China (Nalbuphine, Morphine)

Recruiting
  • Nalbuphine Allergy
  • +2 more
  • Hefei, Anhui, China
  • +19 more
Dec 28, 2022

Polycythemia Vera Trial in Italy (GIVINOSTAT (ITF2357) 50 mg o.d. + MTD Hydroxyurea, GIVINOSTAT (ITF2357) 50 mg b.i.d. + MTD

Completed
  • Polycythemia Vera
  • GIVINOSTAT (ITF2357) 50 mg o.d. + MTD Hydroxyurea
  • GIVINOSTAT (ITF2357) 50 mg b.i.d. + MTD Hydroxyurea
  • Bari, BA, Italy
  • +21 more
Oct 30, 2019